Quanterix Corporation (QTRX) Hit All-Time Low at $13.95 on Jun, 29

June 29, 2018 - By Kevin Carney

On Jun, 29, all time low was touched by Quanterix Corporation (NASDAQ:QTRX). Today’s share price was $13.95. It’s 4.00 % below our $13.39. Barchart.com reported this technical pattern. Quanterix Corporation (NASDAQ:QTRX) has $306.34 million MC. At $13.39 stock target, the company valuation changes by $12.25 million less.

QTRX reached $13.95 during the last trading session after $0.13 change.Quanterix Corporation has volume of 46,443 shares. Since June 29, 2017 QTRX has 0.00% and is . QTRX underperformed the S&P 500 by 12.57%.

Quanterix Corporation (NASDAQ:QTRX)’s quarterly earnings will be published on August, 21., according to Faxor. After $-0.33 EPS was published last quarter, analysts now see EPS growth of -15.15 % for Quanterix Corporation.

For more Quanterix Corporation (NASDAQ:QTRX) news published briefly go to: Benzinga.com, Seekingalpha.com, Businesswire.com, Businesswire.com or Benzinga.com. The titles are as follows: “35 Stocks Moving In Tuesday’s Mid-Day Session” published on June 05, 2018, “Stocks To Watch: Eyes On Apple’s WWDC, SCOTUS And DC” on June 02, 2018, “Hercules Capital on Pace to Potentially Exceed $1.0 Billion in Total New Debt and Equity Commitments in 2018” with a publish date: June 11, 2018, “EY Announces Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix and Founder of …” and the last “45 Biggest Movers From Yesterday” with publication date: June 06, 2018.

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific.The company has $306.34 million market cap. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test.Currently it has negative earnings. The company's products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips.

Quanterix Corporation (NASDAQ:QTRX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: